Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 2

Status

Completed 5

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 4Genitourinary 1Gastrointestinal 1

Conditions

Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic-Myeloproliferative Diseases 2Kidney Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumors 1Recurrence 1Ovarian Neoplasms 1Oligodendroglioma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Liver Neoplasms 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Erythroblastic, Acute 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × perifosine × Clear all
NCT01224730 2018-03-14

A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies

AEterna Zentaris

Phase 1 Completed
24 enrolled
Tumor-Agnostic

Neoplasms

NCT00398814 2014-02-19

Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers

AEterna Zentaris

Phase 1 Completed
30 enrolled
GastrointestinalGenitourinary

Kidney Neoplasms, Liver Neoplasms, Neoplasms

NCT00398697 2014-02-13

Phase I Perifosine and Gemcitabine Study

AEterna Zentaris

Phase 1 Completed
19 enrolled
Tumor-Agnostic

Neoplasms

NCT00399087 2014-02-13

Phase I Trial of Docetaxel With Perifosine

AEterna Zentaris

Phase 1 Completed
39 enrolled
Tumor-Agnostic

Neoplasms

NCT00399126 2014-02-13

Phase I Trial of Paclitaxel With Perifosine

AEterna Zentaris

Phase 1 Completed
24 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡